Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyMarina Elena Cazzaniga, Massimiliano Mazza, G. Pinotti et al.|The Breast|2019Cited by 58
Metronomic Oral Vinorelbine in Advanced Breast Cancer and Non-Small-Cell Lung Cancer: Current Status and Future DevelopmentMarina Elena Cazzaniga, Guido Bocci, Andrea Camerini et al.|Future Oncology|2015Cited by 54
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyMarina Elena Cazzaniga, I. Vallini, Emilia Montagna et al.|Breast Cancer Research and Treatment|2021Cited by 17
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast CancerStefania Gori, Luca Boni, Alessandro Inno et al.|PLoS ONE|2015Cited by 13
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective StudySara Gagno, Giuseppe Toffoli, Mario D’Andrea et al.|Clinical Breast Cancer|2018Cited by 10